[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$foygejmlRrKHfpdG9hgOI3hAJ1qn4-Mxa-7sIVmZ74jg":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":34,"phaseBuckets":85,"rows":92},"University of Monastir",[4],109,false,16,27,77965,19,59,[14,17,20,23,25,27,30,32],{"name":15,"count":16},"Renal Colic",10,{"name":18,"count":19},"Acute Heart Failure",8,{"name":21,"count":22},"Acute Coronary Syndrome",5,{"name":24,"count":22},"Acute Pain",{"name":26,"count":22},"COPD Exacerbation",{"name":28,"count":29},"Atrial Fibrillation",3,{"name":31,"count":29},"Dyspnea; Cardiac",{"name":33,"count":29},"Chronic Obstructive Pulmonary Disease",[35,40,45,50,55,60,65,70,75,80],{"nctId":36,"briefTitle":37,"date":38,"intervention":39},"NCT05369559","Mini Bolus for Fluid Challenge Responsiveness in the Emergency Department","2024-08-22","Mini bolus 50",{"nctId":41,"briefTitle":42,"date":43,"intervention":44},"NCT05636826","Olive Leaf Extracts in the Control of Hypertension","2024-11-22","atherolive-drug",{"nctId":46,"briefTitle":47,"date":48,"intervention":49},"NCT06457646","mRNA Expression and Genetic Polymorphisms Affecting DRD3 (rs6280) and HTR2A (rs6313) in Bruxism","2024-12-15","Genetic polymorphism",{"nctId":51,"briefTitle":52,"date":53,"intervention":54},"NCT06345716","Paracetamol-Tramadol and Paracetamol-caffeine Versus Placebo in the Emergency Discharge Treatment of Renal Colic","2025-03-15","paracétamol tramadol",{"nctId":56,"briefTitle":57,"date":58,"intervention":59},"NCT06900972","Effect of Colloids Versus Crystalloids on Heart Mechanics: a Double-blind Cross Over Randomized Trial","2025-08-30","Gelafundin",{"nctId":61,"briefTitle":62,"date":63,"intervention":64},"NCT05605704","Olive Leaf Extracts in the Control of Diabet","2025-09-15","Atherolive",{"nctId":66,"briefTitle":67,"date":68,"intervention":69},"NCT05325580","Intravenous Magnesium Sulfate Vs Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department","2025-12-01","Magnesium sulfate",{"nctId":71,"briefTitle":72,"date":73,"intervention":74},"NCT06723002","Effect of Olive Leaf Extracts on Endothelial Dysfunction in Patients With Acute Coronary Syndrome","2025-12-30","Atherolive 500mg\u002Fday",{"nctId":76,"briefTitle":77,"date":78,"intervention":79},"NCT05722782","Oral NSAI Versus Acetaminophen or Placebo as a Discharge Treatment of Non Complicated Renal Colics","2027-06","Piroxicam",{"nctId":81,"briefTitle":82,"date":83,"intervention":84},"NCT07596329","Outpatient Hypertonic Saline and Loop Diuretic Combination Therapy in Cardiorenal","2027-11-30","Hypertonic sodium chloride 10%",[86,87,88,89,90,91],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[93,142,178,203,221,247,265,283,309,327,351,369,387,406,438,460,478,496,516,538,572,605,636,663,681,699,725,743,768,786,813,831,856,874,898,916,934,958,976,1003,1021,1046,1064,1089,1116,1134,1159,1177,1202,1220,1238,1263,1298,1316,1342,1360,1378,1406,1424,1442,1460,1484,1505,1544,1575,1602,1626,1644,1667,1691,1709,1727,1750],{"intervention":94,"totalTrials":29,"cells":95},"Magnesium Sulfate",{"EARLY_PHASE1":96,"PHASE1":99,"PHASE2":101,"PHASE3":116,"PHASE4":138,"NA":140},{"trials":97,"activeCount":98},[],0,{"trials":100,"activeCount":98},[],{"trials":102,"activeCount":98},[103],{"nctId":104,"briefTitle":105,"status":106,"phases":107,"primaryCompletion":108,"completion":109,"start":110,"enrollment":111,"conditions":112,"interventions":113},"NCT03199924","Treatment of Renal Colic in the Emergency Departement (ED).","COMPLETED",[88],"2022-01-01","2022-07-31","2016-07-01",600,[15],[114,94,115],"Diclofenac","Lidocaine",{"trials":117,"activeCount":137,"soonestReadout":68},[118,128],{"nctId":119,"briefTitle":120,"status":106,"phases":121,"primaryCompletion":122,"completion":122,"start":123,"enrollment":124,"conditions":125,"interventions":126},"NCT01136421","Magnesium Sulfate Versus Ipratropuim Bromide in Acute Exacerbation of Chronic Obstructive Pulmonary Disease",[89],"2007-06","2005-01",124,[26],[127,94],"Ipratropium bromide",{"nctId":66,"briefTitle":67,"status":129,"phases":130,"primaryCompletion":68,"completion":131,"start":132,"enrollment":133,"conditions":134,"interventions":136},"RECRUITING",[89],"2026-12-30","2021-12-01",424,[135],"Head Pain",[69],1,{"trials":139,"activeCount":98},[],{"trials":141,"activeCount":98},[],{"intervention":143,"totalTrials":144,"cells":145},"atherolive",2,{"EARLY_PHASE1":146,"PHASE1":148,"PHASE2":150,"PHASE3":152,"PHASE4":174,"NA":176},{"trials":147,"activeCount":98},[],{"trials":149,"activeCount":98},[],{"trials":151,"activeCount":98},[],{"trials":153,"activeCount":137,"soonestReadout":63},[154,167],{"nctId":155,"briefTitle":156,"status":157,"phases":158,"primaryCompletion":159,"completion":160,"start":161,"enrollment":162,"conditions":163,"interventions":166},"NCT05297110","Olive Leaf Extracts in the Control of Cardiovascular Risk","UNKNOWN",[88,89],"2023-11-01","2023-12-01","2021-08-01",1000,[164,165],"Diabetes Mellitus, Type 2","Hypertension",[143],{"nctId":61,"briefTitle":62,"status":129,"phases":168,"primaryCompletion":63,"completion":169,"start":170,"enrollment":171,"conditions":172,"interventions":173},[88,89],"2025-12-15","2023-01-01",500,[164],[64],{"trials":175,"activeCount":98},[],{"trials":177,"activeCount":98},[],{"intervention":59,"totalTrials":137,"cells":179},{"EARLY_PHASE1":180,"PHASE1":182,"PHASE2":184,"PHASE3":186,"PHASE4":199,"NA":201},{"trials":181,"activeCount":98},[],{"trials":183,"activeCount":98},[],{"trials":185,"activeCount":98},[],{"trials":187,"activeCount":137,"soonestReadout":58},[188],{"nctId":56,"briefTitle":57,"status":189,"phases":190,"primaryCompletion":58,"completion":191,"start":192,"enrollment":8,"conditions":193,"interventions":197},"ENROLLING_BY_INVITATION",[89],"2025-09-30","2025-04-01",[194,195,196],"Fluid Reponsiveness","Fluid Resuscitation","Fluid Therapy",[59,198],"Saline",{"trials":200,"activeCount":98},[],{"trials":202,"activeCount":98},[],{"intervention":198,"totalTrials":137,"cells":204},{"EARLY_PHASE1":205,"PHASE1":207,"PHASE2":209,"PHASE3":211,"PHASE4":217,"NA":219},{"trials":206,"activeCount":98},[],{"trials":208,"activeCount":98},[],{"trials":210,"activeCount":98},[],{"trials":212,"activeCount":137,"soonestReadout":58},[213],{"nctId":56,"briefTitle":57,"status":189,"phases":214,"primaryCompletion":58,"completion":191,"start":192,"enrollment":8,"conditions":215,"interventions":216},[89],[194,195,196],[59,198],{"trials":218,"activeCount":98},[],{"trials":220,"activeCount":98},[],{"intervention":84,"totalTrials":137,"cells":222},{"EARLY_PHASE1":223,"PHASE1":225,"PHASE2":227,"PHASE3":229,"PHASE4":243,"NA":245},{"trials":224,"activeCount":98},[],{"trials":226,"activeCount":98},[],{"trials":228,"activeCount":98},[],{"trials":230,"activeCount":137,"soonestReadout":83},[231],{"nctId":81,"briefTitle":82,"status":232,"phases":233,"primaryCompletion":83,"completion":234,"start":235,"enrollment":236,"conditions":237,"interventions":240},"NOT_YET_RECRUITING",[89],"2027-12-30","2026-05-01",60,[238,239],"Heart Failure","Renal Disease, Chronic",[84,241,242],"Sodium Chloride 0.9%","Furosemide intravenous solution",{"trials":244,"activeCount":98},[],{"trials":246,"activeCount":98},[],{"intervention":241,"totalTrials":137,"cells":248},{"EARLY_PHASE1":249,"PHASE1":251,"PHASE2":253,"PHASE3":255,"PHASE4":261,"NA":263},{"trials":250,"activeCount":98},[],{"trials":252,"activeCount":98},[],{"trials":254,"activeCount":98},[],{"trials":256,"activeCount":137,"soonestReadout":83},[257],{"nctId":81,"briefTitle":82,"status":232,"phases":258,"primaryCompletion":83,"completion":234,"start":235,"enrollment":236,"conditions":259,"interventions":260},[89],[238,239],[84,241,242],{"trials":262,"activeCount":98},[],{"trials":264,"activeCount":98},[],{"intervention":242,"totalTrials":137,"cells":266},{"EARLY_PHASE1":267,"PHASE1":269,"PHASE2":271,"PHASE3":273,"PHASE4":279,"NA":281},{"trials":268,"activeCount":98},[],{"trials":270,"activeCount":98},[],{"trials":272,"activeCount":98},[],{"trials":274,"activeCount":137,"soonestReadout":83},[275],{"nctId":81,"briefTitle":82,"status":232,"phases":276,"primaryCompletion":83,"completion":234,"start":235,"enrollment":236,"conditions":277,"interventions":278},[89],[238,239],[84,241,242],{"trials":280,"activeCount":98},[],{"trials":282,"activeCount":98},[],{"intervention":284,"totalTrials":137,"cells":285},"Terbutaline 2.5 mg",{"EARLY_PHASE1":286,"PHASE1":288,"PHASE2":290,"PHASE3":292,"PHASE4":305,"NA":307},{"trials":287,"activeCount":98},[],{"trials":289,"activeCount":98},[],{"trials":291,"activeCount":98},[],{"trials":293,"activeCount":137,"soonestReadout":298},[294],{"nctId":295,"briefTitle":296,"status":232,"phases":297,"primaryCompletion":298,"completion":299,"start":300,"enrollment":301,"conditions":302,"interventions":303},"NCT06980727","Comparative Efficacy of IV Dexamethasone vs. Nebulized Terbutaline for Renal Colic Pain in the ED",[89],"2027-12-01","2028-03-01","2026-08-08",300,[15],[284,304],"Dexamethasone",{"trials":306,"activeCount":98},[],{"trials":308,"activeCount":98},[],{"intervention":304,"totalTrials":137,"cells":310},{"EARLY_PHASE1":311,"PHASE1":313,"PHASE2":315,"PHASE3":317,"PHASE4":323,"NA":325},{"trials":312,"activeCount":98},[],{"trials":314,"activeCount":98},[],{"trials":316,"activeCount":98},[],{"trials":318,"activeCount":137,"soonestReadout":298},[319],{"nctId":295,"briefTitle":296,"status":232,"phases":320,"primaryCompletion":298,"completion":299,"start":300,"enrollment":301,"conditions":321,"interventions":322},[89],[15],[284,304],{"trials":324,"activeCount":98},[],{"trials":326,"activeCount":98},[],{"intervention":74,"totalTrials":137,"cells":328},{"EARLY_PHASE1":329,"PHASE1":331,"PHASE2":333,"PHASE3":335,"PHASE4":347,"NA":349},{"trials":330,"activeCount":98},[],{"trials":332,"activeCount":98},[],{"trials":334,"activeCount":98},[],{"trials":336,"activeCount":137,"soonestReadout":73},[337],{"nctId":71,"briefTitle":72,"status":232,"phases":338,"primaryCompletion":73,"completion":73,"start":339,"enrollment":301,"conditions":340,"interventions":344},[88,89],"2024-12-01",[341,342,343],"Acute Coronary Syndrome (ACS)","Reactive Hyperemia","Endothelial Dysfunction",[74,345,346],"Atherolive 1000\u002Fday","Placbo_Atherolive",{"trials":348,"activeCount":98},[],{"trials":350,"activeCount":98},[],{"intervention":345,"totalTrials":137,"cells":352},{"EARLY_PHASE1":353,"PHASE1":355,"PHASE2":357,"PHASE3":359,"PHASE4":365,"NA":367},{"trials":354,"activeCount":98},[],{"trials":356,"activeCount":98},[],{"trials":358,"activeCount":98},[],{"trials":360,"activeCount":137,"soonestReadout":73},[361],{"nctId":71,"briefTitle":72,"status":232,"phases":362,"primaryCompletion":73,"completion":73,"start":339,"enrollment":301,"conditions":363,"interventions":364},[88,89],[341,342,343],[74,345,346],{"trials":366,"activeCount":98},[],{"trials":368,"activeCount":98},[],{"intervention":346,"totalTrials":137,"cells":370},{"EARLY_PHASE1":371,"PHASE1":373,"PHASE2":375,"PHASE3":377,"PHASE4":383,"NA":385},{"trials":372,"activeCount":98},[],{"trials":374,"activeCount":98},[],{"trials":376,"activeCount":98},[],{"trials":378,"activeCount":137,"soonestReadout":73},[379],{"nctId":71,"briefTitle":72,"status":232,"phases":380,"primaryCompletion":73,"completion":73,"start":339,"enrollment":301,"conditions":381,"interventions":382},[88,89],[341,342,343],[74,345,346],{"trials":384,"activeCount":98},[],{"trials":386,"activeCount":98},[],{"intervention":44,"totalTrials":137,"cells":388},{"EARLY_PHASE1":389,"PHASE1":391,"PHASE2":393,"PHASE3":395,"PHASE4":402,"NA":404},{"trials":390,"activeCount":98},[],{"trials":392,"activeCount":98},[],{"trials":394,"activeCount":98},[],{"trials":396,"activeCount":137,"soonestReadout":43},[397],{"nctId":41,"briefTitle":42,"status":129,"phases":398,"primaryCompletion":43,"completion":73,"start":399,"enrollment":171,"conditions":400,"interventions":401},[88,89],"2023-12-30",[165],[44],{"trials":403,"activeCount":98},[],{"trials":405,"activeCount":98},[],{"intervention":79,"totalTrials":144,"cells":407},{"EARLY_PHASE1":408,"PHASE1":410,"PHASE2":412,"PHASE3":421,"PHASE4":434,"NA":436},{"trials":409,"activeCount":98},[],{"trials":411,"activeCount":98},[],{"trials":413,"activeCount":137,"soonestReadout":78},[414],{"nctId":76,"briefTitle":77,"status":129,"phases":415,"primaryCompletion":78,"completion":416,"start":417,"enrollment":171,"conditions":418,"interventions":419},[88],"2027-12","2023-07-01",[15],[79,420],"Acetaminophen",{"trials":422,"activeCount":98},[423],{"nctId":424,"briefTitle":425,"status":106,"phases":426,"primaryCompletion":427,"completion":428,"start":429,"enrollment":430,"conditions":431,"interventions":432},"NCT02304783","Oral NSAI Versus Paracetamol or Placebo as a Second Line Treatment for Renal Colics",[89],"2021-06","2021-12","2014-01",1400,[15],[79,433],"paracetamol",{"trials":435,"activeCount":98},[],{"trials":437,"activeCount":98},[],{"intervention":54,"totalTrials":137,"cells":439},{"EARLY_PHASE1":440,"PHASE1":442,"PHASE2":444,"PHASE3":454,"PHASE4":456,"NA":458},{"trials":441,"activeCount":98},[],{"trials":443,"activeCount":98},[],{"trials":445,"activeCount":137,"soonestReadout":53},[446],{"nctId":51,"briefTitle":52,"status":129,"phases":447,"primaryCompletion":53,"completion":448,"start":449,"enrollment":450,"conditions":451,"interventions":452},[88],"2025-11-30","2024-04-10",1500,[15],[54,453],"Paracétamol cafeine",{"trials":455,"activeCount":98},[],{"trials":457,"activeCount":98},[],{"trials":459,"activeCount":98},[],{"intervention":453,"totalTrials":137,"cells":461},{"EARLY_PHASE1":462,"PHASE1":464,"PHASE2":466,"PHASE3":472,"PHASE4":474,"NA":476},{"trials":463,"activeCount":98},[],{"trials":465,"activeCount":98},[],{"trials":467,"activeCount":137,"soonestReadout":53},[468],{"nctId":51,"briefTitle":52,"status":129,"phases":469,"primaryCompletion":53,"completion":448,"start":449,"enrollment":450,"conditions":470,"interventions":471},[88],[15],[54,453],{"trials":473,"activeCount":98},[],{"trials":475,"activeCount":98},[],{"trials":477,"activeCount":98},[],{"intervention":420,"totalTrials":137,"cells":479},{"EARLY_PHASE1":480,"PHASE1":482,"PHASE2":484,"PHASE3":490,"PHASE4":492,"NA":494},{"trials":481,"activeCount":98},[],{"trials":483,"activeCount":98},[],{"trials":485,"activeCount":137,"soonestReadout":78},[486],{"nctId":76,"briefTitle":77,"status":129,"phases":487,"primaryCompletion":78,"completion":416,"start":417,"enrollment":171,"conditions":488,"interventions":489},[88],[15],[79,420],{"trials":491,"activeCount":98},[],{"trials":493,"activeCount":98},[],{"trials":495,"activeCount":98},[],{"intervention":39,"totalTrials":137,"cells":497},{"EARLY_PHASE1":498,"PHASE1":506,"PHASE2":508,"PHASE3":510,"PHASE4":512,"NA":514},{"trials":499,"activeCount":137,"soonestReadout":38},[500],{"nctId":36,"briefTitle":37,"status":129,"phases":501,"primaryCompletion":38,"completion":502,"start":503,"enrollment":162,"conditions":504,"interventions":505},[86],"2025-05-22","2022-03-03",[196],[39],{"trials":507,"activeCount":98},[],{"trials":509,"activeCount":98},[],{"trials":511,"activeCount":98},[],{"trials":513,"activeCount":98},[],{"trials":515,"activeCount":98},[],{"intervention":49,"totalTrials":137,"cells":517},{"EARLY_PHASE1":518,"PHASE1":520,"PHASE2":522,"PHASE3":524,"PHASE4":526,"NA":528},{"trials":519,"activeCount":98},[],{"trials":521,"activeCount":98},[],{"trials":523,"activeCount":98},[],{"trials":525,"activeCount":98},[],{"trials":527,"activeCount":98},[],{"trials":529,"activeCount":137,"soonestReadout":48},[530],{"nctId":46,"briefTitle":47,"status":232,"phases":531,"primaryCompletion":48,"completion":532,"start":533,"enrollment":534,"conditions":535,"interventions":537},[],"2024-12-17","2024-06-02",169,[536],"Bruxism",[49],{"intervention":539,"totalTrials":144,"cells":540},"Morphine Titration",{"EARLY_PHASE1":541,"PHASE1":543,"PHASE2":545,"PHASE3":556,"PHASE4":568,"NA":570},{"trials":542,"activeCount":98},[],{"trials":544,"activeCount":98},[],{"trials":546,"activeCount":98},[547],{"nctId":548,"briefTitle":549,"status":106,"phases":550,"primaryCompletion":551,"completion":551,"start":552,"enrollment":301,"conditions":553,"interventions":554},"NCT02460913","Acupuncture Versus Intravenous Morphine in the Management of Acute Pain in the Emergency Department",[88],"2013-03","2012-04",[24],[555],"Morphine titration",{"trials":557,"activeCount":98},[558],{"nctId":559,"briefTitle":560,"status":106,"phases":561,"primaryCompletion":562,"completion":563,"start":564,"enrollment":565,"conditions":566,"interventions":567},"NCT02781415","Acupuncture Versus Titrated Morphine in Patients With Renal Colic",[89],"2015-07","2016-06","2014-07",200,[15],[539],{"trials":569,"activeCount":98},[],{"trials":571,"activeCount":98},[],{"intervention":573,"totalTrials":144,"cells":574},"Ketamine",{"EARLY_PHASE1":575,"PHASE1":577,"PHASE2":579,"PHASE3":591,"PHASE4":601,"NA":603},{"trials":576,"activeCount":98},[],{"trials":578,"activeCount":98},[],{"trials":580,"activeCount":98},[581],{"nctId":582,"briefTitle":583,"status":106,"phases":584,"primaryCompletion":585,"completion":585,"start":586,"enrollment":587,"conditions":588,"interventions":590},"NCT03233035","Low Dose Ketamine Intra Nasal Traumatology",[88],"2018-12-01","2018-01-01",1102,[589],"Trauma",[573],{"trials":592,"activeCount":98},[593],{"nctId":594,"briefTitle":595,"status":157,"phases":596,"primaryCompletion":597,"completion":68,"start":598,"enrollment":162,"conditions":599,"interventions":600},"NCT05229055","Intranasal Ketamine Versus Subcutaneous Ketamine for Treatment of Post-traumatic Acute Pain in the Emergency Department ( INVESCK )",[88,89],"2024-05-30","2023-04-15",[24],[573],{"trials":602,"activeCount":98},[],{"trials":604,"activeCount":98},[],{"intervention":606,"totalTrials":144,"cells":607},"Levofloxacin 500mg",{"EARLY_PHASE1":608,"PHASE1":610,"PHASE2":612,"PHASE3":622,"PHASE4":632,"NA":634},{"trials":609,"activeCount":98},[],{"trials":611,"activeCount":98},[],{"trials":613,"activeCount":98},[614],{"nctId":615,"briefTitle":616,"status":106,"phases":617,"primaryCompletion":618,"completion":618,"start":586,"enrollment":619,"conditions":620,"interventions":621},"NCT03698682","Short Compared With Standard Duration of Antibiotic Treatment for AECOPD",[88],"2021-01-31",310,[33],[606],{"trials":623,"activeCount":98},[624],{"nctId":625,"briefTitle":626,"status":106,"phases":627,"primaryCompletion":628,"completion":628,"start":629,"enrollment":619,"conditions":630,"interventions":631},"NCT02067780","Short Antibiotic Treatment Versus Duration Guided by Markers of Inflammation in the Treatment of AECOPD",[89],"2019-01-31","2017-05-01",[33],[606],{"trials":633,"activeCount":98},[],{"trials":635,"activeCount":98},[],{"intervention":637,"totalTrials":137,"cells":638},"Magnesium Sulfate high dose",{"EARLY_PHASE1":639,"PHASE1":641,"PHASE2":643,"PHASE3":645,"PHASE4":659,"NA":661},{"trials":640,"activeCount":98},[],{"trials":642,"activeCount":98},[],{"trials":644,"activeCount":98},[],{"trials":646,"activeCount":98},[647],{"nctId":648,"briefTitle":649,"status":106,"phases":650,"primaryCompletion":651,"completion":652,"start":653,"enrollment":654,"conditions":655,"interventions":656},"NCT00965874","Low Versus High Dose Magnesium Sulfate in the Early Management of Rapid Atrial Fibrillation",[89],"2014-04","2014-08","2009-11",450,[28],[637,657,658],"Magnesium Sulfate low dose","Placebos",{"trials":660,"activeCount":98},[],{"trials":662,"activeCount":98},[],{"intervention":657,"totalTrials":137,"cells":664},{"EARLY_PHASE1":665,"PHASE1":667,"PHASE2":669,"PHASE3":671,"PHASE4":677,"NA":679},{"trials":666,"activeCount":98},[],{"trials":668,"activeCount":98},[],{"trials":670,"activeCount":98},[],{"trials":672,"activeCount":98},[673],{"nctId":648,"briefTitle":649,"status":106,"phases":674,"primaryCompletion":651,"completion":652,"start":653,"enrollment":654,"conditions":675,"interventions":676},[89],[28],[637,657,658],{"trials":678,"activeCount":98},[],{"trials":680,"activeCount":98},[],{"intervention":658,"totalTrials":137,"cells":682},{"EARLY_PHASE1":683,"PHASE1":685,"PHASE2":687,"PHASE3":689,"PHASE4":695,"NA":697},{"trials":684,"activeCount":98},[],{"trials":686,"activeCount":98},[],{"trials":688,"activeCount":98},[],{"trials":690,"activeCount":98},[691],{"nctId":648,"briefTitle":649,"status":106,"phases":692,"primaryCompletion":651,"completion":652,"start":653,"enrollment":654,"conditions":693,"interventions":694},[89],[28],[637,657,658],{"trials":696,"activeCount":98},[],{"trials":698,"activeCount":98},[],{"intervention":700,"totalTrials":137,"cells":701},"NSAID",{"EARLY_PHASE1":702,"PHASE1":704,"PHASE2":706,"PHASE3":708,"PHASE4":721,"NA":723},{"trials":703,"activeCount":98},[],{"trials":705,"activeCount":98},[],{"trials":707,"activeCount":98},[],{"trials":709,"activeCount":98},[710],{"nctId":711,"briefTitle":712,"status":106,"phases":713,"primaryCompletion":714,"completion":714,"start":715,"enrollment":450,"conditions":716,"interventions":718},"NCT03222518","NSAIDs Versus Paracetamol Versus Paracetamol + NSAIDs in Traumatic Pain Management",[89],"2018-11-01","2017-03-01",[717],"Acute Pain Due to Trauma",[719,700,720],"Paracetamol","paracetamol-NSAID",{"trials":722,"activeCount":98},[],{"trials":724,"activeCount":98},[],{"intervention":720,"totalTrials":137,"cells":726},{"EARLY_PHASE1":727,"PHASE1":729,"PHASE2":731,"PHASE3":733,"PHASE4":739,"NA":741},{"trials":728,"activeCount":98},[],{"trials":730,"activeCount":98},[],{"trials":732,"activeCount":98},[],{"trials":734,"activeCount":98},[735],{"nctId":711,"briefTitle":712,"status":106,"phases":736,"primaryCompletion":714,"completion":714,"start":715,"enrollment":450,"conditions":737,"interventions":738},[89],[717],[719,700,720],{"trials":740,"activeCount":98},[],{"trials":742,"activeCount":98},[],{"intervention":744,"totalTrials":137,"cells":745},"Digoxin 0.25 mg",{"EARLY_PHASE1":746,"PHASE1":748,"PHASE2":750,"PHASE3":752,"PHASE4":764,"NA":766},{"trials":747,"activeCount":98},[],{"trials":749,"activeCount":98},[],{"trials":751,"activeCount":98},[],{"trials":753,"activeCount":98},[754],{"nctId":755,"briefTitle":756,"status":157,"phases":757,"primaryCompletion":170,"completion":160,"start":758,"enrollment":759,"conditions":760,"interventions":762},"NCT05540600","Left Atrium Reservoir Function Modulation in Patients With Atrial Fibrillation: Digoxin Versus Beta Blocker",[89],"2022-09-12",30,[28,761],"Left Atrial Rhythm",[744,763],"Bisoprolol",{"trials":765,"activeCount":98},[],{"trials":767,"activeCount":98},[],{"intervention":763,"totalTrials":137,"cells":769},{"EARLY_PHASE1":770,"PHASE1":772,"PHASE2":774,"PHASE3":776,"PHASE4":782,"NA":784},{"trials":771,"activeCount":98},[],{"trials":773,"activeCount":98},[],{"trials":775,"activeCount":98},[],{"trials":777,"activeCount":98},[778],{"nctId":755,"briefTitle":756,"status":157,"phases":779,"primaryCompletion":170,"completion":160,"start":758,"enrollment":759,"conditions":780,"interventions":781},[89],[28,761],[744,763],{"trials":783,"activeCount":98},[],{"trials":785,"activeCount":98},[],{"intervention":787,"totalTrials":137,"cells":788},"ciprofloxacin",{"EARLY_PHASE1":789,"PHASE1":791,"PHASE2":793,"PHASE3":795,"PHASE4":809,"NA":811},{"trials":790,"activeCount":98},[],{"trials":792,"activeCount":98},[],{"trials":794,"activeCount":98},[],{"trials":796,"activeCount":98},[797],{"nctId":798,"briefTitle":799,"status":106,"phases":800,"primaryCompletion":801,"completion":801,"start":802,"enrollment":803,"conditions":804,"interventions":807},"NCT00791505","Antibiotic\u002FCOPD in Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) Requiring Mechanical Ventilation",[89],"2005-06","2002-07",170,[33,805,806],"Sepsis","Antibiotics",[787,808],"trimethoprim-sulfamethoxazole",{"trials":810,"activeCount":98},[],{"trials":812,"activeCount":98},[],{"intervention":808,"totalTrials":137,"cells":814},{"EARLY_PHASE1":815,"PHASE1":817,"PHASE2":819,"PHASE3":821,"PHASE4":827,"NA":829},{"trials":816,"activeCount":98},[],{"trials":818,"activeCount":98},[],{"trials":820,"activeCount":98},[],{"trials":822,"activeCount":98},[823],{"nctId":798,"briefTitle":799,"status":106,"phases":824,"primaryCompletion":801,"completion":801,"start":802,"enrollment":803,"conditions":825,"interventions":826},[89],[33,805,806],[787,808],{"trials":828,"activeCount":98},[],{"trials":830,"activeCount":98},[],{"intervention":832,"totalTrials":137,"cells":833},"Diazepam 5mg",{"EARLY_PHASE1":834,"PHASE1":836,"PHASE2":838,"PHASE3":840,"PHASE4":852,"NA":854},{"trials":835,"activeCount":98},[],{"trials":837,"activeCount":98},[],{"trials":839,"activeCount":98},[],{"trials":841,"activeCount":98},[842],{"nctId":843,"briefTitle":844,"status":157,"phases":845,"primaryCompletion":73,"completion":846,"start":847,"enrollment":162,"conditions":848,"interventions":850},"NCT06293989","Efficacy and Safety of Intravenous Diazepam Given at 2 Different Doses Compared to Placebo in Acute Peripheral Vertigo",[89],"2026-03-30","2024-05-01",[849],"Vertigo, Peripheral",[832,851],"Diazepam 10 mg",{"trials":853,"activeCount":98},[],{"trials":855,"activeCount":98},[],{"intervention":851,"totalTrials":137,"cells":857},{"EARLY_PHASE1":858,"PHASE1":860,"PHASE2":862,"PHASE3":864,"PHASE4":870,"NA":872},{"trials":859,"activeCount":98},[],{"trials":861,"activeCount":98},[],{"trials":863,"activeCount":98},[],{"trials":865,"activeCount":98},[866],{"nctId":843,"briefTitle":844,"status":157,"phases":867,"primaryCompletion":73,"completion":846,"start":847,"enrollment":162,"conditions":868,"interventions":869},[89],[849],[832,851],{"trials":871,"activeCount":98},[],{"trials":873,"activeCount":98},[],{"intervention":875,"totalTrials":137,"cells":876},"Paracetamol Codeine",{"EARLY_PHASE1":877,"PHASE1":879,"PHASE2":881,"PHASE3":883,"PHASE4":894,"NA":896},{"trials":878,"activeCount":98},[],{"trials":880,"activeCount":98},[],{"trials":882,"activeCount":98},[],{"trials":884,"activeCount":98},[885],{"nctId":886,"briefTitle":887,"status":106,"phases":888,"primaryCompletion":889,"completion":889,"start":890,"enrollment":450,"conditions":891,"interventions":892},"NCT05229965","Paracetamol Vs Caffeine Vs Codeine in the Management of Post Traumatic Pain in Emergencies",[89],"2023-06-27","2022-11-01",[717],[719,875,893],"Paracetamol caféine",{"trials":895,"activeCount":98},[],{"trials":897,"activeCount":98},[],{"intervention":893,"totalTrials":137,"cells":899},{"EARLY_PHASE1":900,"PHASE1":902,"PHASE2":904,"PHASE3":906,"PHASE4":912,"NA":914},{"trials":901,"activeCount":98},[],{"trials":903,"activeCount":98},[],{"trials":905,"activeCount":98},[],{"trials":907,"activeCount":98},[908],{"nctId":886,"briefTitle":887,"status":106,"phases":909,"primaryCompletion":889,"completion":889,"start":890,"enrollment":450,"conditions":910,"interventions":911},[89],[717],[719,875,893],{"trials":913,"activeCount":98},[],{"trials":915,"activeCount":98},[],{"intervention":127,"totalTrials":137,"cells":917},{"EARLY_PHASE1":918,"PHASE1":920,"PHASE2":922,"PHASE3":924,"PHASE4":930,"NA":932},{"trials":919,"activeCount":98},[],{"trials":921,"activeCount":98},[],{"trials":923,"activeCount":98},[],{"trials":925,"activeCount":98},[926],{"nctId":119,"briefTitle":120,"status":106,"phases":927,"primaryCompletion":122,"completion":122,"start":123,"enrollment":124,"conditions":928,"interventions":929},[89],[26],[127,94],{"trials":931,"activeCount":98},[],{"trials":933,"activeCount":98},[],{"intervention":935,"totalTrials":137,"cells":936},"nebulized morphine",{"EARLY_PHASE1":937,"PHASE1":939,"PHASE2":941,"PHASE3":943,"PHASE4":954,"NA":956},{"trials":938,"activeCount":98},[],{"trials":940,"activeCount":98},[],{"trials":942,"activeCount":98},[],{"trials":944,"activeCount":98},[945],{"nctId":946,"briefTitle":947,"status":106,"phases":948,"primaryCompletion":564,"completion":564,"start":949,"enrollment":565,"conditions":950,"interventions":952},"NCT01123551","Efficacy Study of Nebulized Morphine and Intravenous Morphine in Post Traumatic Pain",[89],"2010-06",[951],"Post Traumatic Pain",[935,953],"Intravenous morphine",{"trials":955,"activeCount":98},[],{"trials":957,"activeCount":98},[],{"intervention":953,"totalTrials":137,"cells":959},{"EARLY_PHASE1":960,"PHASE1":962,"PHASE2":964,"PHASE3":966,"PHASE4":972,"NA":974},{"trials":961,"activeCount":98},[],{"trials":963,"activeCount":98},[],{"trials":965,"activeCount":98},[],{"trials":967,"activeCount":98},[968],{"nctId":946,"briefTitle":947,"status":106,"phases":969,"primaryCompletion":564,"completion":564,"start":949,"enrollment":565,"conditions":970,"interventions":971},[89],[951],[935,953],{"trials":973,"activeCount":98},[],{"trials":975,"activeCount":98},[],{"intervention":977,"totalTrials":137,"cells":978},"Vit-D 0.2 MG\u002FML Oral Solution [Calcidol]",{"EARLY_PHASE1":979,"PHASE1":981,"PHASE2":983,"PHASE3":985,"PHASE4":999,"NA":1001},{"trials":980,"activeCount":98},[],{"trials":982,"activeCount":98},[],{"trials":984,"activeCount":98},[],{"trials":986,"activeCount":98},[987],{"nctId":988,"briefTitle":989,"status":106,"phases":990,"primaryCompletion":991,"completion":992,"start":993,"enrollment":994,"conditions":995,"interventions":997},"NCT04883203","The Effect of Vitamin D Supplementation on COVID-19 Recovery",[89],"2020-09-30","2020-10-31","2020-04-22",130,[996],"Covid19",[977,998],"Physiological Irrigating Solution",{"trials":1000,"activeCount":98},[],{"trials":1002,"activeCount":98},[],{"intervention":998,"totalTrials":137,"cells":1004},{"EARLY_PHASE1":1005,"PHASE1":1007,"PHASE2":1009,"PHASE3":1011,"PHASE4":1017,"NA":1019},{"trials":1006,"activeCount":98},[],{"trials":1008,"activeCount":98},[],{"trials":1010,"activeCount":98},[],{"trials":1012,"activeCount":98},[1013],{"nctId":988,"briefTitle":989,"status":106,"phases":1014,"primaryCompletion":991,"completion":992,"start":993,"enrollment":994,"conditions":1015,"interventions":1016},[89],[996],[977,998],{"trials":1018,"activeCount":98},[],{"trials":1020,"activeCount":98},[],{"intervention":1022,"totalTrials":137,"cells":1023},"Soulagel®",{"EARLY_PHASE1":1024,"PHASE1":1026,"PHASE2":1028,"PHASE3":1030,"PHASE4":1042,"NA":1044},{"trials":1025,"activeCount":98},[],{"trials":1027,"activeCount":98},[],{"trials":1029,"activeCount":98},[],{"trials":1031,"activeCount":98},[1032],{"nctId":1033,"briefTitle":1034,"status":106,"phases":1035,"primaryCompletion":1036,"completion":1036,"start":1037,"enrollment":1038,"conditions":1039,"interventions":1040},"NCT05054023","Topical Piroxicam vs Soulagel in the Treatment of Acute Extremity Pain After Emergency Department Discharge",[88,89],"2022-03-21","2021-10-21",1525,[24],[1022,1041],"Arthrosyl®",{"trials":1043,"activeCount":98},[],{"trials":1045,"activeCount":98},[],{"intervention":1041,"totalTrials":137,"cells":1047},{"EARLY_PHASE1":1048,"PHASE1":1050,"PHASE2":1052,"PHASE3":1054,"PHASE4":1060,"NA":1062},{"trials":1049,"activeCount":98},[],{"trials":1051,"activeCount":98},[],{"trials":1053,"activeCount":98},[],{"trials":1055,"activeCount":98},[1056],{"nctId":1033,"briefTitle":1034,"status":106,"phases":1057,"primaryCompletion":1036,"completion":1036,"start":1037,"enrollment":1038,"conditions":1058,"interventions":1059},[88,89],[24],[1022,1041],{"trials":1061,"activeCount":98},[],{"trials":1063,"activeCount":98},[],{"intervention":1065,"totalTrials":137,"cells":1066},"GIK and intensive insulin therapy",{"EARLY_PHASE1":1067,"PHASE1":1069,"PHASE2":1071,"PHASE3":1073,"PHASE4":1085,"NA":1087},{"trials":1068,"activeCount":98},[],{"trials":1070,"activeCount":98},[],{"trials":1072,"activeCount":98},[],{"trials":1074,"activeCount":98},[1075],{"nctId":1076,"briefTitle":1077,"status":106,"phases":1078,"primaryCompletion":1079,"completion":1080,"start":1081,"enrollment":1082,"conditions":1083,"interventions":1084},"NCT00965406","Glucose Insulin Potassium With Intensive Insulin Therapy and (GIK2) Versus GIK Alone",[89],"2013-12","2014-06","2010-08",772,[21],[1065],{"trials":1086,"activeCount":98},[],{"trials":1088,"activeCount":98},[],{"intervention":1090,"totalTrials":137,"cells":1091},"Bricanyl\u002FIprovent",{"EARLY_PHASE1":1092,"PHASE1":1094,"PHASE2":1096,"PHASE3":1098,"PHASE4":1112,"NA":1114},{"trials":1093,"activeCount":98},[],{"trials":1095,"activeCount":98},[],{"trials":1097,"activeCount":98},[],{"trials":1099,"activeCount":98},[1100],{"nctId":1101,"briefTitle":1102,"status":106,"phases":1103,"primaryCompletion":1104,"completion":1105,"start":1106,"enrollment":1107,"conditions":1108,"interventions":1110},"NCT01944033","β2-agonist Versus Ipratropium Bromide Associated With β2-agonists in Chronic Obstructive Pulmonary Disease Exacerbation",[89],"2016-07","2017-01","2013-07",250,[1109],"Acute Exacerbation of Chronic Obstructive Airways Disease",[1090,1111],"Bricanyl",{"trials":1113,"activeCount":98},[],{"trials":1115,"activeCount":98},[],{"intervention":1111,"totalTrials":137,"cells":1117},{"EARLY_PHASE1":1118,"PHASE1":1120,"PHASE2":1122,"PHASE3":1124,"PHASE4":1130,"NA":1132},{"trials":1119,"activeCount":98},[],{"trials":1121,"activeCount":98},[],{"trials":1123,"activeCount":98},[],{"trials":1125,"activeCount":98},[1126],{"nctId":1101,"briefTitle":1102,"status":106,"phases":1127,"primaryCompletion":1104,"completion":1105,"start":1106,"enrollment":1107,"conditions":1128,"interventions":1129},[89],[1109],[1090,1111],{"trials":1131,"activeCount":98},[],{"trials":1133,"activeCount":98},[],{"intervention":1135,"totalTrials":137,"cells":1136},"Magnesium sulfate and diclofenac",{"EARLY_PHASE1":1137,"PHASE1":1139,"PHASE2":1141,"PHASE3":1153,"PHASE4":1155,"NA":1157},{"trials":1138,"activeCount":98},[],{"trials":1140,"activeCount":98},[],{"trials":1142,"activeCount":98},[1143],{"nctId":1144,"briefTitle":1145,"status":106,"phases":1146,"primaryCompletion":1147,"completion":1147,"start":1148,"enrollment":1149,"conditions":1150,"interventions":1151},"NCT05653401","Treatment of Renal Colic in the Emergency Department: Comparison Between Magnesium Sulfate and Lidocaine.",[88],"2023-08-01","2022-11-20",800,[15],[1135,1152],"Lidocain and diclofenac",{"trials":1154,"activeCount":98},[],{"trials":1156,"activeCount":98},[],{"trials":1158,"activeCount":98},[],{"intervention":1152,"totalTrials":137,"cells":1160},{"EARLY_PHASE1":1161,"PHASE1":1163,"PHASE2":1165,"PHASE3":1171,"PHASE4":1173,"NA":1175},{"trials":1162,"activeCount":98},[],{"trials":1164,"activeCount":98},[],{"trials":1166,"activeCount":98},[1167],{"nctId":1144,"briefTitle":1145,"status":106,"phases":1168,"primaryCompletion":1147,"completion":1147,"start":1148,"enrollment":1149,"conditions":1169,"interventions":1170},[88],[15],[1135,1152],{"trials":1172,"activeCount":98},[],{"trials":1174,"activeCount":98},[],{"trials":1176,"activeCount":98},[],{"intervention":1178,"totalTrials":137,"cells":1179},"Sodium Chloride 0.9% Intravenous",{"EARLY_PHASE1":1180,"PHASE1":1182,"PHASE2":1184,"PHASE3":1196,"PHASE4":1198,"NA":1200},{"trials":1181,"activeCount":98},[],{"trials":1183,"activeCount":98},[],{"trials":1185,"activeCount":98},[1186],{"nctId":1187,"briefTitle":1188,"status":106,"phases":1189,"primaryCompletion":1190,"completion":1191,"start":651,"enrollment":1192,"conditions":1193,"interventions":1195},"NCT02142985","Respiratory Variation in Central Venous Oxygen Saturation Predicts Volume Responsiveness in Hemodynamically Unstable Patients Under Mechanical Ventilation : a Prospective Cohort Study",[88],"2015-04","2015-10",88,[1194],"Hemodynamic Instability",[1178],{"trials":1197,"activeCount":98},[],{"trials":1199,"activeCount":98},[],{"trials":1201,"activeCount":98},[],{"intervention":114,"totalTrials":137,"cells":1203},{"EARLY_PHASE1":1204,"PHASE1":1206,"PHASE2":1208,"PHASE3":1214,"PHASE4":1216,"NA":1218},{"trials":1205,"activeCount":98},[],{"trials":1207,"activeCount":98},[],{"trials":1209,"activeCount":98},[1210],{"nctId":104,"briefTitle":105,"status":106,"phases":1211,"primaryCompletion":108,"completion":109,"start":110,"enrollment":111,"conditions":1212,"interventions":1213},[88],[15],[114,94,115],{"trials":1215,"activeCount":98},[],{"trials":1217,"activeCount":98},[],{"trials":1219,"activeCount":98},[],{"intervention":115,"totalTrials":137,"cells":1221},{"EARLY_PHASE1":1222,"PHASE1":1224,"PHASE2":1226,"PHASE3":1232,"PHASE4":1234,"NA":1236},{"trials":1223,"activeCount":98},[],{"trials":1225,"activeCount":98},[],{"trials":1227,"activeCount":98},[1228],{"nctId":104,"briefTitle":105,"status":106,"phases":1229,"primaryCompletion":108,"completion":109,"start":110,"enrollment":111,"conditions":1230,"interventions":1231},[88],[15],[114,94,115],{"trials":1233,"activeCount":98},[],{"trials":1235,"activeCount":98},[],{"trials":1237,"activeCount":98},[],{"intervention":1239,"totalTrials":137,"cells":1240},"Esomeprazole",{"EARLY_PHASE1":1241,"PHASE1":1243,"PHASE2":1245,"PHASE3":1257,"PHASE4":1259,"NA":1261},{"trials":1242,"activeCount":98},[],{"trials":1244,"activeCount":98},[],{"trials":1246,"activeCount":98},[1247],{"nctId":1248,"briefTitle":1249,"status":106,"phases":1250,"primaryCompletion":1251,"completion":1252,"start":1253,"enrollment":171,"conditions":1254,"interventions":1256},"NCT05287633","Proton Pump Inhibitors Effects on Dyspepsia During Ramadan Fasting",[87,88],"2020-12-15","2024-12-30","2020-01-20",[1255],"Dyspepsia",[1239],{"trials":1258,"activeCount":98},[],{"trials":1260,"activeCount":98},[],{"trials":1262,"activeCount":98},[],{"intervention":1264,"totalTrials":144,"cells":1265},"LOVENOX",{"EARLY_PHASE1":1266,"PHASE1":1268,"PHASE2":1290,"PHASE3":1292,"PHASE4":1294,"NA":1296},{"trials":1267,"activeCount":98},[],{"trials":1269,"activeCount":98},[1270,1279],{"nctId":1271,"briefTitle":1272,"status":106,"phases":1273,"primaryCompletion":429,"completion":1080,"start":1274,"enrollment":1275,"conditions":1276,"interventions":1277},"NCT02152423","Enoxamed Study in the Treatment of Acute Coronary Syndromes",[87],"2013-06",50,[21],[1264,1278],"ENOXAMED",{"nctId":1280,"briefTitle":1281,"status":106,"phases":1282,"primaryCompletion":1283,"completion":429,"start":1284,"enrollment":1285,"conditions":1286,"interventions":1287},"NCT04552067","Enoxaparin Bioequivalence Study in Acute Coronary Syndrome Patients",[87],"2013-04","2012-12",172,[21],[1288,1289],"Lovenox","Enoxaparin",{"trials":1291,"activeCount":98},[],{"trials":1293,"activeCount":98},[],{"trials":1295,"activeCount":98},[],{"trials":1297,"activeCount":98},[],{"intervention":1278,"totalTrials":137,"cells":1299},{"EARLY_PHASE1":1300,"PHASE1":1302,"PHASE2":1308,"PHASE3":1310,"PHASE4":1312,"NA":1314},{"trials":1301,"activeCount":98},[],{"trials":1303,"activeCount":98},[1304],{"nctId":1271,"briefTitle":1272,"status":106,"phases":1305,"primaryCompletion":429,"completion":1080,"start":1274,"enrollment":1275,"conditions":1306,"interventions":1307},[87],[21],[1264,1278],{"trials":1309,"activeCount":98},[],{"trials":1311,"activeCount":98},[],{"trials":1313,"activeCount":98},[],{"trials":1315,"activeCount":98},[],{"intervention":1317,"totalTrials":137,"cells":1318},"Budesonide",{"EARLY_PHASE1":1319,"PHASE1":1321,"PHASE2":1334,"PHASE3":1336,"PHASE4":1338,"NA":1340},{"trials":1320,"activeCount":98},[],{"trials":1322,"activeCount":98},[1323],{"nctId":1324,"briefTitle":1325,"status":157,"phases":1326,"primaryCompletion":1327,"completion":1328,"start":1329,"enrollment":236,"conditions":1330,"interventions":1332},"NCT04016220","Nebulized Budesonide Combined With Systemic Corticosteroid in Acute Severe Asthma",[87],"2019-12-20","2020-05-20","2019-05-20",[1331],"Acute Asthma",[1317,1333],"normal saline",{"trials":1335,"activeCount":98},[],{"trials":1337,"activeCount":98},[],{"trials":1339,"activeCount":98},[],{"trials":1341,"activeCount":98},[],{"intervention":1333,"totalTrials":137,"cells":1343},{"EARLY_PHASE1":1344,"PHASE1":1346,"PHASE2":1352,"PHASE3":1354,"PHASE4":1356,"NA":1358},{"trials":1345,"activeCount":98},[],{"trials":1347,"activeCount":98},[1348],{"nctId":1324,"briefTitle":1325,"status":157,"phases":1349,"primaryCompletion":1327,"completion":1328,"start":1329,"enrollment":236,"conditions":1350,"interventions":1351},[87],[1331],[1317,1333],{"trials":1353,"activeCount":98},[],{"trials":1355,"activeCount":98},[],{"trials":1357,"activeCount":98},[],{"trials":1359,"activeCount":98},[],{"intervention":1289,"totalTrials":137,"cells":1361},{"EARLY_PHASE1":1362,"PHASE1":1364,"PHASE2":1370,"PHASE3":1372,"PHASE4":1374,"NA":1376},{"trials":1363,"activeCount":98},[],{"trials":1365,"activeCount":98},[1366],{"nctId":1280,"briefTitle":1281,"status":106,"phases":1367,"primaryCompletion":1283,"completion":429,"start":1284,"enrollment":1285,"conditions":1368,"interventions":1369},[87],[21],[1288,1289],{"trials":1371,"activeCount":98},[],{"trials":1373,"activeCount":98},[],{"trials":1375,"activeCount":98},[],{"trials":1377,"activeCount":98},[],{"intervention":1379,"totalTrials":137,"cells":1380},"IV NSAI",{"EARLY_PHASE1":1381,"PHASE1":1383,"PHASE2":1398,"PHASE3":1400,"PHASE4":1402,"NA":1404},{"trials":1382,"activeCount":98},[],{"trials":1384,"activeCount":98},[1385],{"nctId":1386,"briefTitle":1387,"status":106,"phases":1388,"primaryCompletion":1389,"completion":1390,"start":1391,"enrollment":1392,"conditions":1393,"interventions":1394},"NCT02156596","IV NSAI Versus Nebulized Morphine Analgesia for First-line Renal Colic",[87],"2017-12","2018-02","2013-02",100,[15],[1379,1395,1396,1397],"NM","IV Serum Saline","Nebulised Serum Saline",{"trials":1399,"activeCount":98},[],{"trials":1401,"activeCount":98},[],{"trials":1403,"activeCount":98},[],{"trials":1405,"activeCount":98},[],{"intervention":1395,"totalTrials":137,"cells":1407},{"EARLY_PHASE1":1408,"PHASE1":1410,"PHASE2":1416,"PHASE3":1418,"PHASE4":1420,"NA":1422},{"trials":1409,"activeCount":98},[],{"trials":1411,"activeCount":98},[1412],{"nctId":1386,"briefTitle":1387,"status":106,"phases":1413,"primaryCompletion":1389,"completion":1390,"start":1391,"enrollment":1392,"conditions":1414,"interventions":1415},[87],[15],[1379,1395,1396,1397],{"trials":1417,"activeCount":98},[],{"trials":1419,"activeCount":98},[],{"trials":1421,"activeCount":98},[],{"trials":1423,"activeCount":98},[],{"intervention":1396,"totalTrials":137,"cells":1425},{"EARLY_PHASE1":1426,"PHASE1":1428,"PHASE2":1434,"PHASE3":1436,"PHASE4":1438,"NA":1440},{"trials":1427,"activeCount":98},[],{"trials":1429,"activeCount":98},[1430],{"nctId":1386,"briefTitle":1387,"status":106,"phases":1431,"primaryCompletion":1389,"completion":1390,"start":1391,"enrollment":1392,"conditions":1432,"interventions":1433},[87],[15],[1379,1395,1396,1397],{"trials":1435,"activeCount":98},[],{"trials":1437,"activeCount":98},[],{"trials":1439,"activeCount":98},[],{"trials":1441,"activeCount":98},[],{"intervention":1397,"totalTrials":137,"cells":1443},{"EARLY_PHASE1":1444,"PHASE1":1446,"PHASE2":1452,"PHASE3":1454,"PHASE4":1456,"NA":1458},{"trials":1445,"activeCount":98},[],{"trials":1447,"activeCount":98},[1448],{"nctId":1386,"briefTitle":1387,"status":106,"phases":1449,"primaryCompletion":1389,"completion":1390,"start":1391,"enrollment":1392,"conditions":1450,"interventions":1451},[87],[15],[1379,1395,1396,1397],{"trials":1453,"activeCount":98},[],{"trials":1455,"activeCount":98},[],{"trials":1457,"activeCount":98},[],{"trials":1459,"activeCount":98},[],{"intervention":1461,"totalTrials":137,"cells":1462},"Douloff",{"EARLY_PHASE1":1463,"PHASE1":1465,"PHASE2":1476,"PHASE3":1478,"PHASE4":1480,"NA":1482},{"trials":1464,"activeCount":98},[],{"trials":1466,"activeCount":98},[1467],{"nctId":1468,"briefTitle":1469,"status":157,"phases":1470,"primaryCompletion":1471,"completion":1471,"start":417,"enrollment":1472,"conditions":1473,"interventions":1475},"NCT05647681","Analgesic Effect of a New Analgesic Based Gel(Douloff) Versus Oral Paracetamol in Acute Soft Injuries",[87],"2024-07-31",1100,[1474],"Analgesia",[1461,433],{"trials":1477,"activeCount":98},[],{"trials":1479,"activeCount":98},[],{"trials":1481,"activeCount":98},[],{"trials":1483,"activeCount":98},[],{"intervention":1485,"totalTrials":137,"cells":1486},"Morphine",{"EARLY_PHASE1":1487,"PHASE1":1495,"PHASE2":1497,"PHASE3":1499,"PHASE4":1501,"NA":1503},{"trials":1488,"activeCount":98},[1489],{"nctId":1490,"briefTitle":1491,"status":106,"phases":1492,"primaryCompletion":1283,"completion":651,"start":552,"enrollment":1392,"conditions":1493,"interventions":1494},"NCT02152410","Acupuncture Versus IV Morphine in the Treatment of Acute Pain in ED",[86],[15],[1485],{"trials":1496,"activeCount":98},[],{"trials":1498,"activeCount":98},[],{"trials":1500,"activeCount":98},[],{"trials":1502,"activeCount":98},[],{"trials":1504,"activeCount":98},[],{"intervention":719,"totalTrials":22,"cells":1506},{"EARLY_PHASE1":1507,"PHASE1":1509,"PHASE2":1515,"PHASE3":1517,"PHASE4":1531,"NA":1533},{"trials":1508,"activeCount":98},[],{"trials":1510,"activeCount":98},[1511],{"nctId":1468,"briefTitle":1469,"status":157,"phases":1512,"primaryCompletion":1471,"completion":1471,"start":417,"enrollment":1472,"conditions":1513,"interventions":1514},[87],[1474],[1461,433],{"trials":1516,"activeCount":98},[],{"trials":1518,"activeCount":98},[1519,1523,1527],{"nctId":711,"briefTitle":712,"status":106,"phases":1520,"primaryCompletion":714,"completion":714,"start":715,"enrollment":450,"conditions":1521,"interventions":1522},[89],[717],[719,700,720],{"nctId":424,"briefTitle":425,"status":106,"phases":1524,"primaryCompletion":427,"completion":428,"start":429,"enrollment":430,"conditions":1525,"interventions":1526},[89],[15],[79,433],{"nctId":886,"briefTitle":887,"status":106,"phases":1528,"primaryCompletion":889,"completion":889,"start":890,"enrollment":450,"conditions":1529,"interventions":1530},[89],[717],[719,875,893],{"trials":1532,"activeCount":98},[],{"trials":1534,"activeCount":98},[1535],{"nctId":1536,"briefTitle":1537,"status":106,"phases":1538,"primaryCompletion":1539,"completion":1539,"start":1540,"enrollment":450,"conditions":1541,"interventions":1542},"NCT03243006","Effect of Early Pain Management at Triage on Opioid Consumption",[91],"2016-09-30","2016-01-01",[24],[719,1543],"Tramadol\u002FParacetamol combination",{"intervention":1545,"totalTrials":144,"cells":1546},"Digoxin",{"EARLY_PHASE1":1547,"PHASE1":1549,"PHASE2":1551,"PHASE3":1553,"PHASE4":1563,"NA":1565},{"trials":1548,"activeCount":98},[],{"trials":1550,"activeCount":98},[],{"trials":1552,"activeCount":98},[],{"trials":1554,"activeCount":98},[1555],{"nctId":1556,"briefTitle":1557,"status":157,"phases":1558,"primaryCompletion":1559,"completion":1559,"start":1560,"enrollment":171,"conditions":1561,"interventions":1562},"NCT02544815","Digoxin Short Term Treatment Assessment Randomized Trial in AHF",[89],"2025-07-31","2023-05-01",[18],[1545],{"trials":1564,"activeCount":98},[],{"trials":1566,"activeCount":98},[1567],{"nctId":1568,"briefTitle":1569,"status":106,"phases":1570,"primaryCompletion":1571,"completion":1571,"start":1106,"enrollment":1572,"conditions":1573,"interventions":1574},"NCT02167165","Role of SNP and DIGOXIN Response in Atrial Fibrillation Patients",[],"2016-12",150,[28],[1545],{"intervention":1576,"totalTrials":137,"cells":1577},"Nicotine patch",{"EARLY_PHASE1":1578,"PHASE1":1580,"PHASE2":1582,"PHASE3":1584,"PHASE4":1586,"NA":1588},{"trials":1579,"activeCount":98},[],{"trials":1581,"activeCount":98},[],{"trials":1583,"activeCount":98},[],{"trials":1585,"activeCount":98},[],{"trials":1587,"activeCount":98},[],{"trials":1589,"activeCount":98},[1590],{"nctId":1591,"briefTitle":1592,"status":106,"phases":1593,"primaryCompletion":1594,"completion":1595,"start":1596,"enrollment":1597,"conditions":1598,"interventions":1601},"NCT03209622","Smoking Cessation After Acute Coronary Syndrome",[91],"2017-11-01","2019-12-30","2015-01-02",89,[1599,21,1600],"Smoking","Recurrence",[1576],{"intervention":1603,"totalTrials":137,"cells":1604},"biochemical parameters",{"EARLY_PHASE1":1605,"PHASE1":1607,"PHASE2":1609,"PHASE3":1611,"PHASE4":1613,"NA":1615},{"trials":1606,"activeCount":98},[],{"trials":1608,"activeCount":98},[],{"trials":1610,"activeCount":98},[],{"trials":1612,"activeCount":98},[],{"trials":1614,"activeCount":98},[],{"trials":1616,"activeCount":98},[1617],{"nctId":1618,"briefTitle":1619,"status":106,"phases":1620,"primaryCompletion":1621,"completion":1621,"start":1106,"enrollment":171,"conditions":1622,"interventions":1625},"NCT02720133","Ramadan Fasting Effects in Patients With Cardiovascular Risk Factors",[],"2015-09",[1623,1624],"Cardiovascular Risk Factors","Fasting",[1603],{"intervention":1543,"totalTrials":137,"cells":1627},{"EARLY_PHASE1":1628,"PHASE1":1630,"PHASE2":1632,"PHASE3":1634,"PHASE4":1636,"NA":1638},{"trials":1629,"activeCount":98},[],{"trials":1631,"activeCount":98},[],{"trials":1633,"activeCount":98},[],{"trials":1635,"activeCount":98},[],{"trials":1637,"activeCount":98},[],{"trials":1639,"activeCount":98},[1640],{"nctId":1536,"briefTitle":1537,"status":106,"phases":1641,"primaryCompletion":1539,"completion":1539,"start":1540,"enrollment":450,"conditions":1642,"interventions":1643},[91],[24],[719,1543],{"intervention":1645,"totalTrials":137,"cells":1646},"C-reactive protein measurement",{"EARLY_PHASE1":1647,"PHASE1":1649,"PHASE2":1651,"PHASE3":1653,"PHASE4":1655,"NA":1657},{"trials":1648,"activeCount":98},[],{"trials":1650,"activeCount":98},[],{"trials":1652,"activeCount":98},[],{"trials":1654,"activeCount":98},[],{"trials":1656,"activeCount":98},[],{"trials":1658,"activeCount":98},[1659],{"nctId":1660,"briefTitle":1661,"status":106,"phases":1662,"primaryCompletion":1079,"completion":1079,"start":1663,"enrollment":171,"conditions":1664,"interventions":1666},"NCT02730585","Diagnostic Performance of C Reactive Protein and Delta CRP in Acute Appendicitis",[],"2010-01",[1665],"Appendicitis",[1645],{"intervention":1668,"totalTrials":137,"cells":1669},"IV titrated morphine",{"EARLY_PHASE1":1670,"PHASE1":1672,"PHASE2":1674,"PHASE3":1676,"PHASE4":1678,"NA":1680},{"trials":1671,"activeCount":98},[],{"trials":1673,"activeCount":98},[],{"trials":1675,"activeCount":98},[],{"trials":1677,"activeCount":98},[],{"trials":1679,"activeCount":98},[],{"trials":1681,"activeCount":98},[1682],{"nctId":1683,"briefTitle":1684,"status":106,"phases":1685,"primaryCompletion":564,"completion":564,"start":552,"enrollment":301,"conditions":1686,"interventions":1688},"NCT02200185","Titrated Versus High and Low Dose Nebulized Morphine to Reduce Pain in Emergency Settings",[91],[1687,24],"Post-Traumatic Headache",[1668,1689,1690],"Low dose nebulised morphine","High dose nebulised morphine",{"intervention":1689,"totalTrials":137,"cells":1692},{"EARLY_PHASE1":1693,"PHASE1":1695,"PHASE2":1697,"PHASE3":1699,"PHASE4":1701,"NA":1703},{"trials":1694,"activeCount":98},[],{"trials":1696,"activeCount":98},[],{"trials":1698,"activeCount":98},[],{"trials":1700,"activeCount":98},[],{"trials":1702,"activeCount":98},[],{"trials":1704,"activeCount":98},[1705],{"nctId":1683,"briefTitle":1684,"status":106,"phases":1706,"primaryCompletion":564,"completion":564,"start":552,"enrollment":301,"conditions":1707,"interventions":1708},[91],[1687,24],[1668,1689,1690],{"intervention":1690,"totalTrials":137,"cells":1710},{"EARLY_PHASE1":1711,"PHASE1":1713,"PHASE2":1715,"PHASE3":1717,"PHASE4":1719,"NA":1721},{"trials":1712,"activeCount":98},[],{"trials":1714,"activeCount":98},[],{"trials":1716,"activeCount":98},[],{"trials":1718,"activeCount":98},[],{"trials":1720,"activeCount":98},[],{"trials":1722,"activeCount":98},[1723],{"nctId":1683,"briefTitle":1684,"status":106,"phases":1724,"primaryCompletion":564,"completion":564,"start":552,"enrollment":301,"conditions":1725,"interventions":1726},[91],[1687,24],[1668,1689,1690],{"intervention":1728,"totalTrials":137,"cells":1729},"Isosorbide Dinitrate",{"EARLY_PHASE1":1730,"PHASE1":1732,"PHASE2":1734,"PHASE3":1736,"PHASE4":1738,"NA":1740},{"trials":1731,"activeCount":98},[],{"trials":1733,"activeCount":98},[],{"trials":1735,"activeCount":98},[],{"trials":1737,"activeCount":98},[],{"trials":1739,"activeCount":98},[],{"trials":1741,"activeCount":98},[1742],{"nctId":1743,"briefTitle":1744,"status":106,"phases":1745,"primaryCompletion":1746,"completion":1746,"start":1747,"enrollment":450,"conditions":1748,"interventions":1749},"NCT02135315","Intensive Arterial Pressure Control in Acute Coronary Syndrome",[91],"2020-12-31","2014-03",[21],[1728],{"intervention":1751,"totalTrials":137,"cells":1752},"Hypertonic Saline Solution",{"EARLY_PHASE1":1753,"PHASE1":1755,"PHASE2":1757,"PHASE3":1759,"PHASE4":1761,"NA":1763},{"trials":1754,"activeCount":98},[],{"trials":1756,"activeCount":98},[],{"trials":1758,"activeCount":98},[],{"trials":1760,"activeCount":98},[],{"trials":1762,"activeCount":98},[],{"trials":1764,"activeCount":98},[1765],{"nctId":1766,"briefTitle":1767,"status":157,"phases":1768,"primaryCompletion":1769,"completion":1769,"start":1770,"enrollment":111,"conditions":1771,"interventions":1773},"NCT05298098","Impact of Hypertonic Saline Solution on Acute Decompensated Heart Failure",[91],"2023-09","2018-07-01",[1772],"Acute Decompensated Heart Failure",[1751]]